Search Results

1 - 10 of 120 items :

  • "management" x
  • Rheumatology x
Clear All
Medical evaluation and management of male and female voiding dysfunction: a review

in the United States: a comparative study. Urology, 2004. 63 (3): p. 461-5. 5. PRUTHI, R.S., et al ., Recent trends in the urology workforce in the United States. Urology, 2013. 82 (5): p. 987-93. 6. HAYLEN, B.T., et al ., An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J, 2010. 21 (1): p. 5-26. 7. RADADIA, K.D., et al ., Management of postradical prostatectomy urinary incontinence: a review. Urology, 2018

Open access
EULAR recommendations for the management of rheumatoid arthritis: what is new in 2017 and its applicability in our local setting

in the health cost.[ 10 ] Recommendations for the management of RA from academic and administrative bodies around the world have been published for the practicing rheumatologists. One of these recommendations, the European League of Associations of Rheumatology (EULAR), has been widely adopted in many European and non-European countries. Regular update of the recommendations is being published by the EULAR RA task force. The latest version of the EULAR RA recommendations was finalized and published recently in the journal Annals of the Rheumatic Diseases. [ 11 ] In

Open access
Review of the diagnosis and pharmacological management of pulmonary arterial hypertension in connective tissue disease

agonist (PA) or combination therapy. General management of connective tissue disease-associated pulmonary arterial hypertension Treatment of CTD-PAH includes non-specific therapies including diuretics, oxygen, anticoagulation and digoxin, and specific drug therapies such as calcium channel blockers, PA, endothelin receptor antagonists (ERA) and phosphodiesterase type-5 inhibitors (PDE5-i) in selected patients. When compared to Group 4 PAH, the use of anticoagulant in idiopathic is associated with a higher bleeding event rate (19 vs 5.4 vs 2.4 event per 100

Open access
Hypokalemic periodic paralysis – the importance of patient education

REFERENCES 1. ALKAABI J.M., MUSHTAQ A., AL-MASKARI F.N., MOUSSA N.A., GARIBALLA S. Hypokalemic periodic paralysis: a case series, review of the literature and update of management . Eur J Emerg Med. 2010; 17 (1):45-7. 2. WEBER F., LEHMANN-HORN F. Hypokalemic periodic paralysis . In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. [cited 2018 Aug 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1338/ . 3. KASPER D., FAUCI A., HAUSER S., LONGO D., JAMESON J.L, LOSCALZO J. Harrison’s principles of

Open access
Management of immune-related adverse events in patients treated with immune checkpoint inhibitors– Rheumatology point of view

) were reported. Lately, the American Society of Clinical Oncology (ASCO) has published their guideline for the management of irAE after the use of immunotherapy. 3 2 Immune checkpoint inhibitors and pathophysiology of irAE Activation of T-cells requires costimulation signals from major histocompatibility complex (MHC) to T-cell receptor (TCR) and from CD80/86 to CD28 between T-cells and antigen presenting cells (APCs). CTLA-4 is normally expressed on T-cell as a competitor of CD28 for CD80/86. It blocks the costimulation signal leading to inhibitory response to

Open access
Thyroid Disease (TD), Chronic Obstructive Pulmonary Disease (COPD) and Valvular Heart Disease (VHD) as modifiable risk factors of Atrial Fibrillation

References 1. SHAMLOO, A., DAGRES, N., ARYA, A., & HINDRICKS, G. Atrial fibrillation: A review of modifiable risk factors and preventive strategies, Romanian Journal of Internal Medicine. 2019; 57 (2), 99-109. 2. REDDY, V., TAHA, W., KUNDUMADAM, S., & KHAN, M. Atrial fibrillation and hyperthyroidism: A literature review. Indian heart journal, 2017; 69 (4), 545–550. 3. ROSS D.S., BURCH H.B., COOPER D.S. American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016

Open access
The inhibitors – a challenge for the management of patients with hereditary haemophilia A

influence on the management of patients in the clinic . Eur J Haematol. 2015; 94 Suppl 77:2-6. 18. CARACO M., RE W., EWENSTEIN B. The role of previously untreated patient studies in understanding the development of FVIII inhibitors . Haemophilia. 2016; 22 :22-31. 19. TER AVEST P.C., FISCHER K., MANCUSO M.E., SANTAGOSTINO E., YUSTE V.J., VAN DEN BERG H.M., et al. Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice . J Thromb Haemost. 2008; 6 :2048-2054. 20. MARCUCCI M., MANCUSO M

Open access
Psychological factors and psychosocial interventions for cancer related pain

., MENDOZA ME., YI JC., FISHER HM., KEEFE FJ. Psychological and behavioral approaches to cancer pain management . J Clin Oncol. 2014; 32 (16):1703–11. 8. LINTON SJ., SHAW WS. Impact of psychological factors in the experience of pain . Phys Ther. 2011; 91 (5):700–11. 9. ECCLESTON C., CROMBEZ G. Pain demands attention: A cognitive-affective model of the interruptive function of pain. Psychol Bull. 1999; 125 (3):356–66. 10. VILLEMURE C., BUSHNELL CM. Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain. 2002

Open access
Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia

References 1. PERNEFRI (Indonesian Society of Nephrology and Hypertension). Konsensus manajemen anemia pada penyakit ginjal kronik (Consensus on management of anemia in chronic kidney disease), 2011. Jakarta; 2011, p. 3-15. 2. BUTTARELLO M, PAJOLA R, NOVELO E, REBESCHINI M, GANTARO S, OLIOSI F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol. 2010; 133:949-54. 3. CHUANG CL, LIU RS, WEI YH, HUANG TP, TARNG IC. Early prediction of response to intravenous iron

Open access
Will imaging change the diagnosis and management of giant cell arteritis?

cases of temporal arteritis . Clin Rheumatol. 2012 Feb; 31 (2):231-7 7. LARIA A., LURATI A., SCARPELLINI M. Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up . Open Access Rheumatol. 2017; 15 (9):55-59. 8. SCHMIDT WA., Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology (Oxford). 2018 ; 57( 2):ii22-ii31. 9. DE MIGUEL E., ROXO A., CASTILLO C., PEITEADO D., VILLALBA A., MARTÍN-MOLA E. The utility and sensitivity of colour Doppler ultrasound in

Open access